FDA approves longer-term use of AstraZeneca blood thinner

DietarySupplements (#1) 1502 days ago Health fda approves longer-term astrazeneca blood thinner All   Discuss  | Add To 
(Reuters) - AstraZeneca Plc on Thursday said the U.S. Food and Drug Administration approved a new dose of its blood thinner Brilinta intended for longer-term use in patients with a history of heart attack or a condition known as acute coronary syndrome.

Advertise With Us!

Dietary Supplement & Health Search Engine

Dietary Supplement Reviews from users worldwide. Get up to date dietary supplement information from name brand dietary supplement makers at

Featured Supplements

Advertise With Us!